Early BDNF treatment ameliorates cell loss in the entorhinal cortex of APP transgenic mice.

Nagahara, Alan H; Mateling, Michael; Kovacs, Imre; Wang, Ling; Eggert, Simone; Rockenstein, Edward; Koo, Edward H; Masliah, Eliezer; Tuszynski, Mark H

Nagahara, Alan H; Mateling, Michael; Kovacs, Imre; Wang, Ling; Eggert, Simone; Rockenstein, Edward; Koo, Edward H; Masliah, Eliezer; Tuszynski, Mark H.

Affiliation

Nagahara AH; Department of Neurosciences-0626, University of California, San Diego, La Jolla, California 92093, and Veterans Affairs Medical Center, San Diego, California 92161.

J Neurosci ; 33(39): 15596-602, 2013 Sep 25.

Article in En | MEDLINE | ID: mdl-24068826

Subject(s)

Amyloid beta-Protein Precursor/genetics; Brain-Derived Neurotrophic Factor/genetics; Entorhinal Cortex/pathology; Alzheimer Disease/genetics; Alzheimer Disease/therapy; Amyloid beta-Protein Precursor/metabolism; Animals; Brain-Derived Neurotrophic Factor/metabolism; Cell Death/genetics; Conditioning, Classical; Fear; Genetic Therapy; Hippocampus/pathology; Mice; Mice, Transgenic; Plaque, Amyloid/metabolism; Protein Transport; Synaptophysin/genetics; Synaptophysin/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Amyloid beta-Protein Precursor / Entorhinal Cortex / Brain-Derived Neurotrophic Factor Type of study: Prognostic_studies Limits: Animals Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google